NCT03852303View on ClinicalTrials.gov

Ivermectin Treatment of Persons With Onchocerciasis-associated Epilepsy

PHASE4CompletedINTERVENTIONAL
Enrollment

197

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

March 31, 2019

Study Completion Date

July 1, 2019

Conditions
Epilepsy
Interventions
DRUG

ivermectin

evaluate effect of ivermectin on frequency of seizures

Trial Locations (1)

Unknown

Centre de Recherche en Maladies Tropicales de l'Ituri, Rethy

All Listed Sponsors
collaborator

European Research Council

OTHER

lead

Universiteit Antwerpen

OTHER

NCT03852303 - Ivermectin Treatment of Persons With Onchocerciasis-associated Epilepsy | Biotech Hunter | Biotech Hunter